Proteomics Analysis of siRNA-mediated Silencing of Wilms’ Tumor 1 in the MDA-MB-468 Breast Cancer Cell Line

Oncology Reports - Greece
doi 10.3892/or.2014.3013
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Effects of RNA Interference-Mediated Gene Silencing of JMJD2A on Human Breast Cancer Cell Line MDA-MB-231 in Vitro

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2011English

The Regulation and Mechanisms of EGFR-mediated Apoptosis in MDA-MB-468 Cells.

English

Unusual Roles of Caspase-8 in Triple-Negative Breast Cancer Cell Line MDA-MB-231

International Journal of Oncology
Cancer ResearchOncology
2016English

Characterization of a Novel PTEN Mutation in MDA-MB-453 Breast Carcinoma Cell Line

BMC Cancer
Cancer ResearchOncologyGenetics
2011English

Intrinsic Resistance to 5-Fluorouracil in a Brain Metastatic Variant of Human Breast Cancer Cell Line, MDA-MB-231BR

PLoS ONE
Multidisciplinary
2016English

Profilin-1 Overexpression in MDA-MB-231 Breast Cancer Cells Is Associated With Alterations in Proteomics Biomarkers of Cell Proliferation, Survival, and Motility as Revealed by Global Proteomics Analyses

OMICS A Journal of Integrative Biology
GeneticsMolecular BiologyBiochemistryMolecular MedicineMedicineBiotechnology
2014English

Selective Regain of Egfr Gene Copies in CD44+/CD24-/lowbreast Cancer Cellular Model MDA-MB-468

BMC Cancer
Cancer ResearchOncologyGenetics
2010English

YC-1 Exerts Inhibitory Effects on MDA-MB-468 Breast Cancer Cells by Targeting EGFR in Vitro and in Vivo Under Normoxic Condition

Chinese Journal of Cancer
2012English

Inhibition of PC Cell-Derived Growth Factor (PCDGF, Epithelin/Granulin Precursor) Expression by Antisense PCDGF cDNA Transfection Inhibits Tumorigenicity of the Human Breast Carcinoma Cell Line MDA-MB-468

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2000English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy